Halbert Hargrove Global Advisors’s Teva Pharmaceutical Industries TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-15
Closed -$508 – 663
2026
Q2
$508 Buy
+15
New +$500 ﹤0.01% 531
2015
Q2
– Sell
-4,350
Closed -$271K – 188
2015
Q1
$271K Buy
+4,350
New +$253K 0.09% 150
2014
Q2
– Sell
-6,772
Closed -$358K – 138
2014
Q1
$358K Buy
6,772
+542
+9% +$25K 0.11% 66
2013
Q4
$250K Buy
+6,230
New +$245K 0.08% 108

Other funds holding TEVA

Halbert Hargrove Global Advisors's TEVA Position: Q3 2026 in Review

Halbert Hargrove Global Advisors sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2026, closing a stake of 15 shares — an estimated $508 sold.

Halbert Hargrove Global Advisors first reported a position in TEVA in Q4 2013 and held it in 4 quarters. The position peaked at $358K in Q1 2014. 598 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Halbert Hargrove Global Advisors reported no remaining Teva Pharmaceutical Industries position as of Q3 2026 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 15 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $508.
  • Halbert Hargrove Global Advisors first reported a position in Teva Pharmaceutical Industries in Q4 2013 and held it in 4 quarters.
  • Halbert Hargrove Global Advisors's Teva Pharmaceutical Industries position peaked at $358K in Q1 2014.
  • 598 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.